Bo Piela

Genzyme headquarters

Genzyme Sold To Sanofi-Aventis In $20 Billion Deal

Cambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.

02/16/2011

Follow

Get every new post delivered to your Inbox.

Join 2,451 other followers